Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

948 public trials 78 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

NCT00676260

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Exeter, United Kingdom

View Trial Details

Completed

Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

NCT00762736

Conditions: Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
Locations: Birmingham, Alabama, United States

Huntsville, Alabama, United States

Sierra Vista, Arizona, United States

Sun City, Arizona, United States

View all 78 locations

View Trial Details

Completed

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

NCT00521742

Conditions: Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
Locations: Not specified

View Trial Details

Completed

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

NCT00225264

Conditions: Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
Locations: Chicago, Illinois, United States

View Trial Details

Completed

Effect of Nigella Sativa on Lipid Profiles in Elderly

NCT01531062

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: Internal Medicine Department, Faculty of Medicine, University Indonesia Jakarta, Jakarta Special Capital Region, Indonesia

View Trial Details

Completed

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00286494

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Anaheim, California, United States

Artesia, California, United States

View all 77 locations

View Trial Details

Completed

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

NCT00286468

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Birmingham, Alabama, United States

Peoria, Arizona, United States

Phoenix, Arizona, United States

Anaheim, California, United States

View all 68 locations

View Trial Details

Completed

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

NCT00286455

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Birmingham, Alabama, United States

Peoria, Arizona, United States

Phoenix, Arizona, United States

Anaheim, California, United States

View all 67 locations

View Trial Details

Completed

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

NCT00286442

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Phoenix, Arizona, United States

Anaheim, California, United States

Artesia, California, United States

Fresno, California, United States

View all 56 locations

View Trial Details

Completed

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

NCT00286429

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Phoenix, Arizona, United States

Anaheim, California, United States

Artesia, California, United States

Fresno, California, United States

View all 60 locations

View Trial Details